Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ.
Göbel T, Diehl O, Heering J, Merk D, Angioni C, Wittmann SK, Buscato E, Kottke R, Weizel L, Schader T, Maier TJ, Geisslinger G, Schubert-Zsilavecz M, Steinhilber D, Proschak E, Kahnt AS. Göbel T, et al. Among authors: steinhilber d. Front Pharmacol. 2019 Mar 20;10:263. doi: 10.3389/fphar.2019.00263. eCollection 2019. Front Pharmacol. 2019. PMID: 30949053 Free PMC article.
[Molecular pharmacology and medicinal chemistry of fibrate].
Steinhilber D, Schubert-Zsilavecz M. Steinhilber D, et al. Pharm Unserer Zeit. 2007;36(2):108-12. doi: 10.1002/pauz.200600208. Pharm Unserer Zeit. 2007. PMID: 17424995 Review. German. No abstract available.
[New targets and drugs for treatment of lipid metabolism disorders].
Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M. Rau O, et al. Among authors: steinhilber d. Pharm Unserer Zeit. 2007;36(2):142-8. doi: 10.1002/pauz.200600213. Pharm Unserer Zeit. 2007. PMID: 17425000 Review. German. No abstract available.
The treatment of dyslipidemia--what's left in the pipeline?
Rau O, Zettl H, Popescu L, Steinhilber D, Schubert-Zsilavecz M. Rau O, et al. Among authors: steinhilber d. ChemMedChem. 2008 Feb;3(2):206-21. doi: 10.1002/cmdc.200700165. ChemMedChem. 2008. PMID: 17963209 Review.
Scaffold-hopping cascade yields potent inhibitors of 5-lipoxygenase.
Hofmann B, Franke L, Proschak E, Tanrikulu Y, Schneider P, Steinhilber D, Schneider G. Hofmann B, et al. Among authors: steinhilber d. ChemMedChem. 2008 Oct;3(10):1535-8. doi: 10.1002/cmdc.200800153. ChemMedChem. 2008. PMID: 18688907 No abstract available.
Celecoxib inhibits 5-lipoxygenase.
Maier TJ, Tausch L, Hoernig M, Coste O, Schmidt R, Angioni C, Metzner J, Groesch S, Pergola C, Steinhilber D, Werz O, Geisslinger G. Maier TJ, et al. Among authors: steinhilber d. Biochem Pharmacol. 2008 Oct 1;76(7):862-72. doi: 10.1016/j.bcp.2008.07.009. Epub 2008 Jul 19. Biochem Pharmacol. 2008. PMID: 18692027
PhAST: pharmacophore alignment search tool.
Hähnke V, Hofmann B, Grgat T, Proschak E, Steinhilber D, Schneider G. Hähnke V, et al. Among authors: steinhilber d. J Comput Chem. 2009 Apr 15;30(5):761-71. doi: 10.1002/jcc.21095. J Comput Chem. 2009. PMID: 18727161
305 results